Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years
Regulation of ferroptosis-related signaling pathways in cancer drug resistance GPX4 and FSP1 signaling As mentioned earlier, GPX4 is a GSH-dependent ferroptosis inhibitor that reduces lipid peroxides, whereas FSP1 functions independently of GSH, which acts as an oxidoreduction enzyme reducing coenzyme Q (CoQ) to ubiquinol (CoQH2) at the cell membrane
Treatment of Herpes Simplex Virus Infection
Acetyl-L-Carnitine 250mg 60c by Metabolic Maintenance Acetyl-L-Carnitine by Metabolic Maintenance provides Acetyl-L-Carnitine which has the ability to cross the blood-brain barrier, where it acts as a powerful antioxidant
L., & Thorner, M
Lipids in health and disease